BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24551148)

  • 1. MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Yang X; Zeng Z; Hou Y; Yuan T; Gao C; Jia W; Yi X; Liu M
    PLoS One; 2014; 9(2):e88745. PubMed ID: 24551148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
    Shi Y; Liu Z
    J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
    Jiang JX; Zhang N; Liu ZM; Wang YY
    Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of microRNA 92a Expression and Its Target Protein Bim in Colorectal Cancer.
    Zaki A; Fawzy A; Akel SY; Gamal H; Elshimy RAA
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):723-730. PubMed ID: 35225486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
    Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
    Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
    Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
    Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
    Choi HH; Cho YS; Choi JH; Kim HK; Kim SS; Chae HS
    Oncology; 2019; 97(3):173-179. PubMed ID: 31216561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of microRNA-92a and the related combination biomarkers as promising substrates in predicting risk, recurrence and poor survival of colorectal cancer.
    Peng Q; Shen Y; Lin K; Zou L; Shen Y; Zhu Y
    J Cancer; 2019; 10(14):3154-3171. PubMed ID: 31289586
    [No Abstract]   [Full Text] [Related]  

  • 9. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
    Chen Y; Wang X; Zhu X; Shao S
    Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.
    Liu GH; Zhou ZG; Chen R; Wang MJ; Zhou B; Li Y; Sun XF
    Tumour Biol; 2013 Aug; 34(4):2175-81. PubMed ID: 23625654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis.
    Liu T; Liu D; Guan S; Dong M
    Ann Med; 2021 Dec; 53(1):87-102. PubMed ID: 33108223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer.
    Liu T; Yin L; Yan G; Li C; Wang L
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):86-93. PubMed ID: 29808806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of MicroRNA-18a for Gastric Cancer: a Meta-Analysis.
    Liang Q; Zhang G; Wang J; Sheng S
    Clin Lab; 2018 Jan; 64(1):177-184. PubMed ID: 29479894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis.
    Zhi ML; Liu ZJ; Yi XY; Zhang LJ; Bao YX
    Genet Mol Res; 2015 Dec; 14(4):18018-25. PubMed ID: 26782449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of miR-92a, -143, and -145 expression levels in patients with colorectal adenocarcinoma from Romania.
    Brînzan C; Aşchie M; Cozaru G; Dumitru E; Mitroi A
    Medicine (Baltimore); 2020 Aug; 99(35):e21895. PubMed ID: 32871920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of microRNA-21 in the diagnosis of gastric cancer: a meta-analysis.
    Zeng Z; Wang J; Zhao L; Hu P; Zhang H; Tang X; He D; Tang S; Zeng Z
    PLoS One; 2013; 8(9):e73278. PubMed ID: 24023850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Potential MicroRNAs in CRC: A Meta-Analysis.
    Fathi S; Guessous F; Karkouri M
    Microrna; 2022; 11(3):190-205. PubMed ID: 35616664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.